Apafant structure
|
Common Name | Apafant | ||
---|---|---|---|---|
CAS Number | 105219-56-5 | Molecular Weight | 455.96 | |
Density | 1.5±0.1 g/cm3 | Boiling Point | 720.2±70.0 °C at 760 mmHg | |
Molecular Formula | C22H22ClN5O2S | Melting Point | 186-188ºC | |
MSDS | Chinese USA | Flash Point | 389.4±35.7 °C |
Use of ApafantApafant (WEB 2086), a potent platelet-activating factor (PAF) antagonist, inhibits PAF binding to human PAF receptors with a Ki of 9.9 nM[1]. |
Name | Apafant |
---|---|
Synonym | More Synonyms |
Description | Apafant (WEB 2086), a potent platelet-activating factor (PAF) antagonist, inhibits PAF binding to human PAF receptors with a Ki of 9.9 nM[1]. |
---|---|
Related Catalog | |
Target |
Ki: 9.9 nM (Platelet-activating factor)[1] |
References |
Density | 1.5±0.1 g/cm3 |
---|---|
Boiling Point | 720.2±70.0 °C at 760 mmHg |
Melting Point | 186-188ºC |
Molecular Formula | C22H22ClN5O2S |
Molecular Weight | 455.96 |
Flash Point | 389.4±35.7 °C |
Exact Mass | 455.118286 |
PSA | 100.85000 |
LogP | 1.32 |
Vapour Pressure | 0.0±2.3 mmHg at 25°C |
Index of Refraction | 1.734 |
Storage condition | 2-8°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Hazard Codes | Xn |
---|---|
RIDADR | NONH for all modes of transport |
A pepducin derived from the third intracellular loop of FPR2 is a partial agonist for direct activation of this receptor in neutrophils but a full agonist for cross-talk triggered reactivation of FPR2.
PLoS ONE 9(10) , e109516, (2014) We recently described a novel receptor cross-talk mechanism in neutrophils, unique in that the signals generated by the PAF receptor (PAFR) and the ATP receptor (P2Y2R) transfer formyl peptide recepto... |
|
Neutrophils reduce the parasite burden in Leishmania (Leishmania) amazonensis-infected macrophages.
PLoS ONE 5(11) , e13815, (2010) Studies on the role of neutrophils in Leishmania infection were mainly performed with L. (L) major, whereas less information is available for L. (L) amazonensis. Previous results from our laboratory s... |
|
Effect of sodium tanshinone IIA sulfonate treatment in a rat model of preeclampsia.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 308(3) , R163-72, (2015) Preeclampsia is a disorder of pregnancy with a significant impact on maternal and fetal health. The complexity of this multifactorial condition has precluded development of effective therapies and, al... |
3-[4-(2-Chlorophenyl)-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-2-yl]-1-(morpholin-4-yl)propan-1-one |
1-Propanone, 3-[4-(2-chlorophenyl)-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-2-yl]-1-(4-morpholinyl)- |
4-[3-[4-(2-chlorophenyl)-9-methyl-6h-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-2-yl]-1-oxopropyl]morpholine |
Apafant |
3-[4-(2-Chlorophenyl)-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-2-yl]-1-(4-morpholinyl)-1-propanone |